HS

Heiko SCHUSTER

IG Immatics Biotechnologies Gmbh: 151 patents #8 of 99Top 9%
AM Amgen: 2 patents #1,289 of 2,867Top 45%
EG Evonik Operations Gmbh: 1 patents #547 of 1,233Top 45%
📍 Rötteln, DE: #7 of 115 inventorsTop 7%
Overall (All Time): #5,752 of 4,157,543Top 1%
155
Patents All Time

Issued Patents All Time

Showing 101–125 of 155 patents

Patent #TitleCo-InventorsDate
10899814 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Annika Sonntag, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899813 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Annika Sonntag, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899812 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Annika Sonntag, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899811 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +1 more 2021-01-26
10899810 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +1 more 2021-01-26
10898519 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-26
10894064 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-19
10888584 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-12
10888585 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-12
10888583 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-12
10888587 Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Janet Peper, Philipp Wagner, Hans-Georg Rammensee 2021-01-12
10888582 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-12
10888586 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2021-01-12
10881690 Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Janet Peper, Philipp Wagner, Hans-Georg Rammensee 2021-01-05
10874695 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2020-12-29
10874696 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2020-12-29
10869917 A*03 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Linus Backert, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche +2 more 2020-12-22
10869897 Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Janet Peper, Philipp Wagner, Hans-Georg Rammensee 2020-12-22
10869896 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2020-12-22
10870685 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Annika Sonntag, Daniel Johannes KOWALEWSKI, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2020-12-22
10869890 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2020-12-22
10869891 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2020-12-22
10869892 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2020-12-22
10869893 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2020-12-22
10869894 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk, Daniel Johannes KOWALEWSKI +1 more 2020-12-22